InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,555.74
(
-0.16%
)
US TECH 100
19,014.00
(
-1.10%
)
Dow Jones
40,358.09
(
-0.14%
)
Brent Oil
80.95
(
0.21%
)
Bitcoin
66,537.94
(
0.93%
)
Post# of 252658
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

poorgradstudent

Send PM Follow Ignore
Followers 73
Posts 3426
Boards Moderated 1
Alias Born 04/28/2004

poorgradstudent

Re: mcbio post# 160423

Monday, 04/29/2013 3:36:11 PM

Monday, April 29, 2013 3:36:11 PM

Post# of 252658

Way behind ARQL's tivantinib. How is INCY's MET inhibitor differentiated?



I haven't been great at following this space, but it seems to me that time is not the essence in determining who is ahead in the MET field. Rather, the company that best executes on identifying the population to test will win the day.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up